ACB1	YGR037C	long-chain fatty acid transporter activity*	fatty acid metabolism*	cellular_component unknown		Involved in transport of newly synthesized acyl-CoA esters from the fatty acid synthetase to acyl-Co	acyl-CoA-binding protein (ACBP)/diazepam binding inhibitor (DBI)/endozepine (EP)	Null mutant is viable, slightly reduced growth rate on ethanol
CSR1	YLR380W	phosphatidylinositol transporter activity	cell wall organization and biogenesis*	cytoplasm		chs5 spa2 rescue; isolated as a multicopy suppressor of the lethality of chs5 spa2 double mutant at		Null mutant is viable
DNF1	YER166W	phospholipid-translocating ATPase activity	intracellular protein transport	plasma membrane		Drs2 Neo1 Family	Potential aminophospholipid translocase	viable. drs2 dnf1 mutant grows slowly, massively accumulates intracellular membranes, and exhibits a
DNF2	YDR093W	phospholipid-translocating ATPase activity	intracellular protein transport	plasma membrane		Drs2 Neo1 Family	Potential aminophospholipid translocase	
DNF3	YMR162C	phospholipid-translocating ATPase activity	intracellular protein transport	trans-Golgi network transport vesicle		Drs2 Neo1 Family	Potential aminophospholipid translocase	
GIT1	YCR098C	phospholipid transporter activity	phospholipid transport	plasma membrane	YJL184W	YLR447C		member of the yeast sugar permease family, which consists of 34 proteins.	permease involved in the uptake of glycerophosphoinositol (GroPIns)	Null mutant is viable, exhibits decreased GroPIns transport
GLC3	YEL011W	1,4-alpha-glucan branching enzyme activity	glycogen metabolism	cellular_component unknown	YPR086W		Glycogen branching enzyme	1,4-glucan-6-(1,4-glucano)-transferase	Null mutant is viable, glycogen deficient
NEO1	YIL048W	phospholipid-translocating ATPase activity*	intracellular protein transport	cellular_component unknown		ATPase that leads to neomycin-resistant protein when overexpressed	P-type ATPase	Null mutant is inviable. When overexpressed, Neo1 confers neomycin resistance.
PDR16	YNL231C	phosphatidylinositol transporter activity	response to drug*	cytoplasm	YGL014W	YHR007C	YNL192W		involved in pleiotropic drug resistance by controlling lipids in various cellular compartments; posi	Pdr17p homolog|Sec14p homolog	Null mutant is viable, exhibits hypersensitivity to azole inhibitors of ergosterol biosynthesis, alt
PDR17	YNL264C	phosphatidylinositol transporter activity	response to drug*	cytoplasm	YNL098C	YLR113W	YDR126W		involved in pleiotropic drug resistance by controlling lipids in various cellular compartments; puta	Pdr16p homolog|Sec14p homolog	Null mutant is viable, exhibits no observable phenotypes; pdr16 pdr17 double deletion mutants exhibi
RSB1	YOR049C	phospholipid-translocating ATPase activity	fatty acid transport	plasma membrane*	YCR034W	YFR049W	YOR299W	YOR302W	YPR086W		Resistance to Sphingoid long-chain Base. Putative transporter or flippase that translocates LCBs fro		Cells overproducing Rsb1p show a decrease in accumulation of exogenously added sphingosine and dihyd
SEC14	YMR079W	phosphatidylinositol transporter activity	Golgi to plasma membrane transport*	cytosol	YDL001W		Required for vesicle budding from the Golgi	phosphatidylinositol transfer protein	Null mutant is inviable; other mutations are temperature sensitive
SFH5	YJL145W	phosphatidylinositol transporter activity	phospholipid transport	cellular_component unknown		putative phosphatidylinositol transfer protein	Sec14p homolog	
	YMR034C	sterol transporter activity	biological_process unknown	cellular_component unknown		Hypothetical ORF		
